ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 255 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q1 2023. The put-call ratio across all filers is 0.89 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $660,164 | +22.0% | 21,574 | +7.1% | 0.13% | +9.5% |
| Q3 2023 | $541,027 | -12.1% | 20,135 | +16.7% | 0.12% | -5.7% |
| Q2 2023 | $615,313 | +54.7% | 17,255 | +10.2% | 0.12% | +7.0% |
| Q1 2023 | $397,815 | -42.7% | 15,662 | -8.5% | 0.12% | -82.9% |
| Q4 2022 | $694,468 | +20.2% | 17,122 | -2.1% | 0.67% | +26.9% |
| Q3 2022 | $578,000 | -15.4% | 17,489 | -9.8% | 0.53% | +2.1% |
| Q2 2022 | $683,000 | -27.9% | 19,399 | -5.8% | 0.52% | +16.6% |
| Q1 2022 | $947,000 | -43.7% | 20,602 | -18.8% | 0.45% | -27.1% |
| Q4 2021 | $1,681,000 | – | 25,358 | – | 0.61% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WESTERN FINANCIAL Corp | 820,264 | $54,392,000 | 33.22% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,260,869 | $216,228,000 | 28.00% |
| L1 Capital Pty Ltd | 296,024 | $19,629,000 | 4.93% |
| Aquilo Capital Management, LLC | 407,926 | $27,050,000 | 4.89% |
| Evolutionary Tree Capital Management, LLC | 72,948 | $4,837,000 | 2.86% |
| ACUTA CAPITAL PARTNERS, LLC | 108,000 | $7,161,000 | 2.58% |
| First Light Asset Management, LLC | 536,836 | $35,598,000 | 2.36% |
| Parkman Healthcare Partners LLC | 70,089 | $4,648,000 | 1.08% |
| Hood River Capital Management LLC | 357,082 | $23,678,000 | 0.76% |
| Vanguard Capital Wealth Advisors | 11,099 | $703,565,000 | 0.60% |